Skip to main content
Premium Trial:

Request an Annual Quote

UK Sequencing Provider Buys Illumina Platforms

NEW YORK (GenomeWeb News) – Medical Solutions, a Nottingham, UK-based provider of DNA sequencing and genotyping services, this week announced that it has purchased Illumina’s next-generation sequencing instrument, the Genome Analyzer, and its BeadStation for whole-genome genotyping.
 
According to the firm, it is the first commercial service provider of those platforms in the UK.
 
“Customers have already expressed significant interest in applications run on the Genome Analyzer and BeadStation platforms, and it is our intention to develop strategic partnerships with these early adopters,” Tom Weaver, commercial director of Medical Solutions, said in a statement.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more